Whey protein formula with medium chain triglycerides, carbohydrate, vitamins and minerals
Brand: Infatrini Peptisorb®
PBAC's latest decision on Whey protein formula with medium chain triglycerides, carbohydrate, vitamins and minerals: Deferred (2016). Considered for Dietary management of conditions requiring a source of medium chain triglycerides in infants with fat malabsorption due to liver disease, short gut syndrome, cystic fibrosis, or gastrointestinal disorders.
PBAC outcome
Deferred
Restricted
ICER (AUD/QALY)
Cost-min
cost-minimisation analysis
Submissions
1
first 2016
Submissions
1
2016 → 2016
Eligible population
Infants aged newborn up to 18 months (or up to 9 kg) with fat malabsorption due to liver disease, short gut syndrome, cystic fibrosis, or gastrointestinal disorders.
Therapy area
Metabolic
Line of therapy
Not applicable
Evidence base
Cost-minimisation
Primary endpoint
Cost-minimisation
Comparator
Monogen® (primary); Peptamen Junior® (secondary)
Economic model
Cost-minimisation
ICER note
Minor submission with no economic evaluation; cost comparison basis only (cost per kilojoule of energy).